Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges.
Nika MohannakGemma PattisonKathryn HirdMerrilee NeedhamPublished in: International journal of general medicine (2019)
Dysphagia in inclusion body myositis (IBM) is common and associated with increased mortality and morbidity due to aspiration pneumonia, malnutrition and dehydration. There is currently no consensus on treatment of dysphagia in IBM and outcomes are variable depending on timing of intervention, patient preference and available expertise. There is a paucity of research exploring the pathophysiology of dysphagia in IBM and appropriate investigations. Increased knowledge of the aetiopathogenesis is likely to change the approach to treatment as well as improve the quality of life for patients. This review explores the epidemiology and pathophysiology of dysphagia in IBM and the currently available treatment strategies.
Keyphrases
- end stage renal disease
- randomized controlled trial
- healthcare
- newly diagnosed
- risk factors
- ejection fraction
- interstitial lung disease
- peritoneal dialysis
- cardiovascular events
- cardiovascular disease
- intensive care unit
- metabolic syndrome
- case report
- clinical practice
- insulin resistance
- skeletal muscle
- mechanical ventilation
- acute respiratory distress syndrome
- early onset
- weight loss
- respiratory failure